Skip to content

Effects of Lower Body EMS Training in Postmenopausal Women

Effects of Lower-Body Electrical Muscle Stimulation Combined With Resistance Training on Body Composition, Muscle Function, and Arteriosclerosis-related Markers in Postmenopausal Women: A Three-arm Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07385534
Acronym
LB-EMS-PMW
Enrollment
38
Registered
2026-02-04
Start date
2026-01-23
Completion date
2026-06-14
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Stiffness, Blood Pressure, Arteriosclerosis, Body Composition, Muscle Function, Postmenopausal Women, Sarcopenia

Keywords

Electrical Muscle Stimulation, EMS, Resistance Training, Postmenopausal Women, Body Composition, Vascular Health, Muscle Function

Brief summary

This study evaluates the effects of a 8-week lower body Electrical Muscle Stimulation (EMS) training program on body composition, muscle function, and arteriosclerosis markers in postmenopausal women. Menopause is associated with a rapid decline in estrogen, which increases the risk of sarcopenia (muscle loss) and arterial stiffness (cardiovascular disease). While resistance training is effective for these conditions, participation rates among postmenopausal women are often low. This study investigates whether applying EMS during lower body resistance exercises provides superior benefits compared to resistance training alone or no intervention. Participants will be randomized into three groups: 1. Lower-body EMS combined with Resistance Training Group 2. Resistance Training Only Group 3. Control Group (No intervention) The study aims to verify the efficacy of EMS as a time-efficient and effective alternative exercise modality for improving vascular and musculoskeletal health in this population.

Interventions

DEVICELower-body Electromyostimulation (LB-EMS) device

Electrical stimulation applied to the lower body muscles (85Hz, 350µs) during the main exercise phase

A 50-minute session consisting of a 10-minute warm-up, 30 minutes of main lower body resistance training (4 types of machine-based exercises per session), and a 10-minute cool-down

Sponsors

Seoul National University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

A parallel-group design with three arms: 1) Lower Body EMS combined with Resistance Training, 2) Resistance Training alone, and 3) Control group.

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Post-menopausal women (defined as cessation of menstruation for at least 12 months). * Aged between 50 and 70 years. * Sedentary lifestyle (no participation in regular resistance training programs within the last 6 months). * Able to perform lower body resistance exercise with LB-EMS suit. * Willing to participate in the study and provide informed consent.

Exclusion criteria

* Contraindications for WB-EMS: Presence of implanted electrical devices (e.g., pacemakers, defibrillators), severe bleeding disorders (e.g., hemophilia), abdominal/inguinal hernia, or history of surgery within the last 6 months (including stent insertion). * Severe Chronic Diseases: Diagnosis of severe cardiovascular (e.g., MI, heart failure, arrhythmia), renal, neurological (e.g., epilepsy), or oncological diseases (currently undergoing treatment). * Uncontrolled Cardiovascular Conditions: Uncontrolled hypertension or severe arterial circulatory disorders. * Confounding Medications: Current use of hormone replacement therapy (HRT) for menopause or medications for severe psychiatric disorders (e.g., depression, anxiety). * Acute Conditions \& Others: Acute infection/inflammation, influence of alcohol/drugs, or any other condition deemed unsuitable by the investigator.

Design outcomes

Primary

MeasureTime frameDescription
Body Fat PercentageBaseline and Week 8Assessed using BIA. The proportion of fat mass relative to total body weight. Unit of Measure: %

Secondary

MeasureTime frameDescription
Highest Brachial-ankle Pulse Wave Velocity (baPWV)Baseline and Week 8An indicator of arterial stiffness. Higher values indicate stiffer arteries. Unit of Measure: cm/s
Peak Torque (Knee Extension/Flexion) per body weightBaseline and Week 8The maximum torque produced during isokinetic knee extension and flexion. Assessed at a 60°/s angular velocity. Unit of Measure: Nm (Newton-meters)/kg
Skeletal Muscle MassBaseline and Week 8Assessed using Bioelectrical Impedance Analysis (BIA). Represents the total weight of muscle tissue attached to the skeleton. Unit of Measure: kg
Total Body Fat MassBaseline and Week 8Assessed using BIA. Represents the total weight of adipose tissue in the body. Unit of Measure: kg
Skeletal Muscle Mass Index (SMI)Baseline and Week 8Calculated as appendicular skeletal muscle mass (ASM) divided by height squared (kg/m\^2). Used to assess sarcopenia status. Unit of Measure: kg/m\^2
Waist CircumferenceBaseline and Week 8Measured at the midpoint between the lowest rib and the iliac crest using a standard anthropometric tape, with the participant standing and breathing normally. Unit of Measure: cm
Waist-to-Hip Ratio (WHR)Baseline and Week 8Calculated as waist circumference divided by hip circumference. An indicator of central adiposity and cardiometabolic risk. Unit of Measure: ratio
Estimated Visceral Fat Area (eVFA)Baseline and Week 8Assessed using BIA. Represents the cross-sectional area of visceral adipose tissue surrounding the abdominal organs. Unit of Measure: cm\^2
Average Brachial-ankle Pulse Wave Velocity (baPWV)Baseline and Week 8An indicator of arterial stiffness. Average values indicate stiffer arteries. Unit of Measure: cm/s
Ankle-Brachial Index (ABI)Baseline and Week 8The Ankle-Brachial Index (ABI) is the ratio of the systolic blood pressure measured at the ankle to the systolic blood pressure measured at the brachial artery. It is a non-invasive indicator used to assess the presence and severity of peripheral arterial stenosis or occlusion. Lower ABI values (typically \< 0.9) suggest narrowing or blockage of the arteries in the legs. Unit of Measure: ratio
Systolic Blood Pressure (SBP)Baseline and Week 8Measured using an automated oscillometric device after at least 5 minutes of seated rest. Represents the peak arterial pressure during ventricular contraction. Unit of Measure: mmHg
Diastolic Blood Pressure (DBP)Baseline and Week 8Measured using an automated oscillometric device after at least 5 minutes of seated rest. Represents the minimum arterial pressure during ventricular relaxation. Unit of Measure: mmHg
Pulse Pressure (PP)Baseline and Week 8The difference between systolic and diastolic blood pressure. It is a marker of arterial stiffness. Unit of Measure: mmHg
Mean Arterial Pressure (MAP)Baseline and Week 8Calculated as (SBP + 2 × DBP) / 3. Represents the average arterial pressure during one cardiac cycle. Unit of Measure: mmHg
Total Work Done per body weightBaseline and Week 8The total amount of work performed by the muscle groups during the test protocol(Knee extension/flexion) at an angular velocity of 180°/s. Unit of Measure: Nm/kg

Countries

South Korea

Contacts

PRINCIPAL_INVESTIGATORYeon Soo Kim, MD

Seoul National University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026